Potential biomarkers of ductal carcinoma in situ progression

Potential biomarkers of ductal carcinoma in situ progression

Abstract Background Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment. We aimed to identify potential biomarker...

Full description

Bibliographic Details
Main Authors: Raquel Spinassé Dettogni, Elaine Stur, Ana Carolina Laus, René Aloísio da Costa Vieira, Márcia Maria Chiquitelli Marques, Iara Viana Vidigal Santana, José Zago Pulido, Laura Fregonassi Ribeiro, Narelle de Jesus Parmanhani, Lidiane Pignaton Agostini, Raquel Silva dos Reis, Eldamária de Vargas Wolfgramm dos Santos, Lyvia Neves Rebello Alves, Fernanda Mariano Garcia, Jéssica Aflávio Santos, Diego do Prado Ventorim, Rui Manuel Reis, Iúri Drumond Louro
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Cancer
Subjects:
Ductal carcinoma in situ
Tumor progression
FGF2
GAS1
SFRP1
Online Access:https://doi.org/10.1186/s12885-020-6608-y

Internet

https://doi.org/10.1186/s12885-020-6608-y

Similar Items